Citation Impact
Citing Papers
Platinum-RNA Modifications Following Drug Treatment in S. cerevisiae Identified by Click Chemistry and Enzymatic Mapping
2014
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
2008 Standout
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
2008 Standout
Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis In vitro and In vivo
2007
A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor–dependent tumor growth in vivo
2007
Stem Cell–Derived Culture Models of Hepatitis E Virus Infection
2018 StandoutNobel
Stem cell-derived hepatocytes: A novel model for hepatitis E virus replication
2015
The role of the insulin-like growth factor-1 system in breast cancer
2015
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
2017 StandoutNobel
Astrocytes: biology and pathology
2009 Standout
Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease
2007
Pan-Genotype Hepatitis E Virus Replication in Stem Cell–Derived Hepatocellular Systems
2017 StandoutNobel
From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic mice
2007
The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study
2010
Functional responses and in vivo anti-tumour activity of h7C10: A humanised monoclonal antibody with neutralising activity against the insulin-like growth factor-1 (IGF-1) receptor and insulin/IGF-1 hybrid receptors
2007
Dysregulation of growth factor signaling in human hepatocellular carcinoma
2006
IGF-I mediated survival pathways in normal and malignant cells
2006
AKT/PKB Signaling: Navigating Downstream
2007 Standout
Chemoenzymatic Fc Glycosylation via Engineered Aldehyde Tags
2014 StandoutNobel
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
2007 Standout
Generation of improved humanized mouse models for human infectious diseases
2014
Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer
2006
Insulin-Like Growth Factor (IGF) family and prostate cancer
2006
Akt-regulated pathways in prostate cancer
2005
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Development of a simple and rapid method for producing non‐fucosylated oligomannose containing antibodies with increased effector function
2007
Structure-activity relationship analysis of mitochondrial toxicity caused by antiviral ribonucleoside analogs
2017
Epidemiology of Prostate Cancer
2019 Standout
TFOS DEWS II pathophysiology report
2017 Standout
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Functional innate immunity restricts Hepatitis C Virus infection in induced pluripotent stem cell–derived hepatocytes
2018
Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors
2007
Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer
2005
Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease
2010 Standout
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
Three generations of α,γ-diaminobutyric acid modified poly(propyleneimine) dendrimers and their cisplatin-type platinum complexes
2006
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
TFOS DEWS II Management and Therapy Report
2017 Standout
The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth
2006
Pancreatic Cancer
2010 Standout
Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities
2008 Standout
A computational approach for predicting off-target toxicity of antiviral ribonucleoside analogues to mitochondrial RNA polymerase
2018 StandoutNobel
TFOS DEWS II Sex, Gender, and Hormones Report
2017
Targeted Therapy for Malignant Glioma Patients: Lessons Learned and the Road Ahead
2009
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer
2008
Repositioning HIV protease inhibitors as cancer therapeutics
2008
Natural products in drug discovery
2008 Standout
Taming a beast: lessons from the domestication of hepatitis C virus
2019 StandoutNobel
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Stem cell-derived polarized hepatocytes
2020 StandoutNobel
Insulin-Like Growth Factor 1 Receptor Targeted Therapeutics: Novel Compounds and Novel Treatment Strategies for Cancer Medicine
2008
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
2011 Standout
Phase II Randomized Study of Figitumumab plus Docetaxel and Docetaxel Alone with Crossover for Metastatic Castration-Resistant Prostate Cancer
2014
Cell and tissue engineering for liver disease
2014
Phase I, Pharmacokinetic and Pharmacodynamic Study of the Anti–Insulinlike Growth Factor Type 1 Receptor Monoclonal Antibody CP-751,871 in Patients With Multiple Myeloma
2008
Diabetes and Cancer
2010 Standout
Potential Applications for Circulating Tumor Cells Expressing the Insulin-Like Growth Factor-I Receptor
2007
In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease
2017 StandoutNobel
The Effects of Insulin-like Growth Factor 1 and Growth Hormone on Human Meibomian Gland Epithelial Cells
2014
Combination therapy in combating cancer
2017 Standout
HIV protease inhibitors: a review of molecular selectivity and toxicity
2015
Targeting Signal Transduction Pathways in Colorectal Cancer—More Than Skin Deep
2005
Inflammatory Mechanisms in Obesity
2011 Standout
Accurate Prediction of Drug-Induced Liver Injury Using Stem Cell-Derived Populations
2013
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
2006 Standout
Disrupting insulin-like growth factor signaling as a potential cancer therapy
2007
The type I insulin-like growth factor receptor pathway: a key player in cancer therapeutic resistance
2008
Enzyme Degradable Hyperbranched Polyphosphoester Micellar Nanomedicines for NIR Imaging-Guided Chemo-Photothermal Therapy of Drug-Resistant Cancers
2018
Organocatalysis emerging as a technology
2021 StandoutNobel
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Phase I Dose Escalation Study of the Anti–Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid Tumors
2007
Asymmetric organocatalysis: an enabling technology for medicinal chemistry
2021
Macrophages, Inflammation, and Insulin Resistance
2010 Standout
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
2007
Gene Expression Profiling in the Discovery, Optimization and Development of Novel Drugs: One Universal Screening Platform
2006
Works of Faye Wang being referenced
Effects of BMS-986094, a Guanosine Nucleotide Analogue, on Mitochondrial DNA Synthesis and Function
2016
Endoplasmic Reticulum Stress Links Dyslipidemia to Inhibition of Proteasome Activity and Glucose Transport by HIV Protease Inhibitors
2005
BMS-986001, an HIV Nucleoside Reverse Transcriptase Inhibitor, Does Not Degrade Mitochondrial DNA in Long-Term Primary Cultures of Cells Isolated from Human Kidney, Muscle, and Adipose Tissue
2013
Developing High-Fidelity Hepatotoxicity Models From Pluripotent Stem Cells
2013
Combination Therapy Enhances the Inhibition of Tumor Growth with the Fully Human Anti–Type 1 Insulin-Like Growth Factor Receptor Monoclonal Antibody CP-751,871
2005